PHARMACEUTICAL COMPOSITION CONTAINING NEUREGULIN ISOFORMS
- 专利权人:
- PROTEOSYS AG
- 发明人:
- André SCHRATTENHOLZ
- 申请号：
- US14271749
- 公开号：
- US20140243270A1
- 申请日:
- 2014.05.07
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- A pharmaceutical composition containing a soluble Neuregulin-1 isoform representing Posttranslational Neuregulin-1 modifications.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
- Active soluble post-translationally modified neuregulin isoforms
- Active, soluble, post-translationally modified neuregulin isoforms.
- Post-translationally modified active soluble neuregulin isoforms
- ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
